Immune infiltration analysis suggested an association between the infiltration rate of various immune cells and RPL3L and SDHA expression, opening avenues for further experimental validations of potential regulatory roles for Rpl3l, Myl4 and Sdha in cardiac pathophysiology and therapeutic targeting in DCM. The gene discussed is RPL3L; the disease is familial dilated cardiomyopathy.